Skip to main content
Screener/Healthcare/Biotechnology

ENVB Enveric Biosciences, Inc.

NASDAQ
$3.73+1.86 (+102.20%)
$1.75
$17.84
$3.65
$5.43
EPS (TTM)$-16.81
P/E Ratio
Dividend Yield
Market Cap$1.2M
Volume155.49M
Prev Close$1.82
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$2.2M$-3.81
Q3 '25$274-$1.9M$-10.81-14733.2%-683820.8%
Q2 '25-$132-$2.5M$-0.9730287.9%1908470.5%
Q1 '25$2-$2.2M$-1.22-4051200.0%-109248300.0%
Q4 '24-$225-$3.2M$-18.0936660.9%1402064.9%
Q3 '24-$217-$2.1M$-0.2439084.8%960383.4%
Q2 '24-$35-$1.9M$-0.25242225.7%5369697.1%
Q1 '24$696-$2.5M$-0.61-12271.4%-353005.0%
Get Your Daily Market Recap